Send the following on WhatsApp
Continue to Chathttps://www.marketscreener.com/quote/stock/MENDUS-AB-17946401/news/Immunicum-Presents-Phase-II-Data-Demonstrating-Reduced-MRD-and-Improved-Survival-with-DCP-001-Treatm-37292454/?utm_source=whatsapp&utm_medium=social&utm_campaign=share